Marc Blaustein Finch Therapeutics Group, Inc. (FNCH) insider trading activity

FNCH Quotes by TradingView

Marc Blaustein is Chief Operating Officer of Finch Therapeutics Group, Inc.. Currently has a direct ownership of 27,995 shares of FNCH, which is worth approximately $321,942. The most recent transaction as insider was on Feb 21, 2023, when has been sold 4,619 shares (Common Stock) at a price of $0.38 per share, resulting in proceeds of $1,755. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28K
0% 3M change
0% 12M change
Total Value Held $321,942

Marc Blaustein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2023
SELL
Open market or private sale
$1,755 $0.38 p/Share
4,619 Reduced 14.16%
27,995 Common Stock
Oct 21 2022
SELL
Open market or private sale
$5,054 $1.39 p/Share
3,636 Reduced 10.03%
32,614 Common Stock
Jun 13 2022
BUY
Grant, award, or other acquisition
-
35,000 Added 49.12%
36,250 Common Stock
MB

Marc Blaustein

Chief Operating Officer
Somerville, MA

Track Institutional and Insider Activities on FNCH

Follow Finch Therapeutics Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FNCH shares.

Notify only if

Insider Trading

Get notified when an Finch Therapeutics Group, Inc. insider buys or sells FNCH shares.

Notify only if

News

Receive news related to Finch Therapeutics Group, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FNCH